News

Thursday, 17 May 2012 - 12:41

Dear Partner

The Treatment Action Campaign, SECTION27, Oxfam and MSF will be hosting a meeting prior to the launch of the 3rd TB Conference of South Africa. The 3rd TB Conference entitled “Reaching the Targets” will be hosted in Durban from 12 – 15 June (registration for the conference ends 18 May).

The conference will be launched on 12 June at 4:00 pm. Prior to the launch, from 9:00 am – 2:00 pm, TAC, SECTION27, Oxfam and MSF will hold a meeting for activists, academics, government, community members and patients.

The aim of the meeting will be to better capacitate...

Read more
Wednesday, 16 May 2012 - 17:06

TAC would like to thank the Varsity Kudus for their drive to raise money for the participation of Runners for Life in the upcoming Comrades Marathon.
The Varsity Kudus are a running group based at Wits University in Johannesburg. TAC secretariat member and avid runner, Mark Heywood, belongs to the Kudus club. Runners for Life is a running group of TAC that was organised and is lead by TAC’s General Secretary.
Runners for Life aim to participate in the 2012 Comrades Marathon, South Africa’s gruelling, annual 89km (56 miles) race running between Pietermaritzburg and Durban. This...

Read more
Wednesday, 16 May 2012 - 12:34
The Varsity Kudus is a running group based at Wits University in Johannesburg. TAC secretariat member and avid runner, Mark Heywood, belongs to the Kudus club. Runners for Health is a running group of TAC that was organised and is lead by TAC’s General Secretary, Vuyiseka Dubula.
 
Runners for Health aim to participate in the 2012 Comrades Marathon, South Africa’s gruelling, annual 89km (56 miles) race running between Pietermaritzburg and Durban. This year’s race will take place on 3 June. The Kudus are raising money for Runners for Health's participation in...
Read more
Friday, 11 May 2012 - 13:59

On 15 May 2012, the Supreme Court of Appeal will hear arguments in the case of Aventis Pharma SA and Others v Cipla Life Sciences and Others in the patent dispute over the cancer medicine Docetaxel (brand name Taxotere). The Treatment Action Campaign (TAC) has been admitted to the proceedings as amicus curiae (friend of the court) and is represented by SECTION27. TAC will argue for the protection of the rights of people in need of medicines in disputes of this nature.

On 15 May 2012, the Supreme Court of Appeal will hear arguments in the case of Aventis Pharma SA and Others v...

Read more
Friday, 11 May 2012 - 12:06

On 15 May 2012, the Supreme Court of Appeal will hear arguments in the case of Aventis Pharma SA and Others v Cipla Life Sciences and Others in the patent dispute over the cancer medicine Docetaxel (brand name Taxotere). The Treatment Action Campaign (TAC) has been admitted to the proceedings as amicus curiae (friend of the court) and is represented by SECTION27. TAC will argue for the protection of the rights of people in need of medicines in disputes of this nature.

Docetaxel is used in the treatment of various cancers, including breast and lung cancers. The medicine has also been...

Read more

Pages